nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ORM1—Vandetanib—thyroid cancer	0.188	0.213	CbGbCtD
Pitavastatin—UGT2B7—Epirubicin—thyroid cancer	0.166	0.188	CbGbCtD
Pitavastatin—ABCG2—Vandetanib—thyroid cancer	0.115	0.13	CbGbCtD
Pitavastatin—ALB—Vandetanib—thyroid cancer	0.0792	0.0894	CbGbCtD
Pitavastatin—ABCC2—Sorafenib—thyroid cancer	0.0766	0.0865	CbGbCtD
Pitavastatin—ABCG2—Sorafenib—thyroid cancer	0.0692	0.0782	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—thyroid cancer	0.0465	0.0525	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—thyroid cancer	0.042	0.0474	CbGbCtD
Pitavastatin—CYP2C8—Sorafenib—thyroid cancer	0.0369	0.0416	CbGbCtD
Pitavastatin—CYP2C9—Sorafenib—thyroid cancer	0.0257	0.029	CbGbCtD
Pitavastatin—ABCB1—Sorafenib—thyroid cancer	0.025	0.0282	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—thyroid cancer	0.0151	0.0171	CbGbCtD
Pitavastatin—Interstitial lung disease—Vandetanib—thyroid cancer	0.00429	0.0606	CcSEcCtD
Pitavastatin—Interstitial lung disease—Sorafenib—thyroid cancer	0.00289	0.0409	CcSEcCtD
Pitavastatin—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00232	0.0327	CcSEcCtD
Pitavastatin—Nasopharyngitis—Vandetanib—thyroid cancer	0.00197	0.0278	CcSEcCtD
Pitavastatin—Influenza—Vandetanib—thyroid cancer	0.00191	0.0269	CcSEcCtD
Pitavastatin—Hepatic failure—Sorafenib—thyroid cancer	0.00166	0.0234	CcSEcCtD
Pitavastatin—Renal failure acute—Sorafenib—thyroid cancer	0.00161	0.0228	CcSEcCtD
Pitavastatin—Myositis—Epirubicin—thyroid cancer	0.00154	0.0218	CcSEcCtD
Pitavastatin—Pain in extremity—Sorafenib—thyroid cancer	0.00149	0.021	CcSEcCtD
Pitavastatin—Myositis—Doxorubicin—thyroid cancer	0.00143	0.0202	CcSEcCtD
Pitavastatin—Nasopharyngitis—Sorafenib—thyroid cancer	0.00133	0.0188	CcSEcCtD
Pitavastatin—Muscle spasms—Vandetanib—thyroid cancer	0.00128	0.018	CcSEcCtD
Pitavastatin—Abdominal discomfort—Sorafenib—thyroid cancer	0.00123	0.0174	CcSEcCtD
Pitavastatin—Erectile dysfunction—Sorafenib—thyroid cancer	0.00118	0.0167	CcSEcCtD
Pitavastatin—Arthralgia—Vandetanib—thyroid cancer	0.00113	0.016	CcSEcCtD
Pitavastatin—Jaundice—Sorafenib—thyroid cancer	0.00112	0.0158	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000987	0.0139	CcSEcCtD
Pitavastatin—Insomnia—Vandetanib—thyroid cancer	0.00098	0.0138	CcSEcCtD
Pitavastatin—Dyspepsia—Vandetanib—thyroid cancer	0.000954	0.0135	CcSEcCtD
Pitavastatin—Fatigue—Vandetanib—thyroid cancer	0.000934	0.0132	CcSEcCtD
Pitavastatin—Constipation—Vandetanib—thyroid cancer	0.000927	0.0131	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000886	0.0125	CcSEcCtD
Pitavastatin—Muscle spasms—Sorafenib—thyroid cancer	0.000861	0.0122	CcSEcCtD
Pitavastatin—Abdominal pain—Vandetanib—thyroid cancer	0.000857	0.0121	CcSEcCtD
Pitavastatin—Asthenia—Vandetanib—thyroid cancer	0.000778	0.011	CcSEcCtD
Pitavastatin—Pruritus—Vandetanib—thyroid cancer	0.000767	0.0108	CcSEcCtD
Pitavastatin—Arthralgia—Sorafenib—thyroid cancer	0.000763	0.0108	CcSEcCtD
Pitavastatin—Myalgia—Sorafenib—thyroid cancer	0.000763	0.0108	CcSEcCtD
Pitavastatin—Diarrhoea—Vandetanib—thyroid cancer	0.000741	0.0105	CcSEcCtD
Pitavastatin—Dizziness—Vandetanib—thyroid cancer	0.000717	0.0101	CcSEcCtD
Pitavastatin—Rash—Vandetanib—thyroid cancer	0.000683	0.00965	CcSEcCtD
Pitavastatin—Dermatitis—Vandetanib—thyroid cancer	0.000683	0.00964	CcSEcCtD
Pitavastatin—Headache—Vandetanib—thyroid cancer	0.000679	0.00959	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000666	0.00941	CcSEcCtD
Pitavastatin—Nausea—Vandetanib—thyroid cancer	0.000644	0.00909	CcSEcCtD
Pitavastatin—Dyspepsia—Sorafenib—thyroid cancer	0.000644	0.00909	CcSEcCtD
Pitavastatin—Fatigue—Sorafenib—thyroid cancer	0.00063	0.0089	CcSEcCtD
Pitavastatin—Constipation—Sorafenib—thyroid cancer	0.000625	0.00883	CcSEcCtD
Pitavastatin—Hepatic failure—Epirubicin—thyroid cancer	0.000612	0.00864	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000598	0.00844	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—thyroid cancer	0.000595	0.00841	CcSEcCtD
Pitavastatin—Urticaria—Sorafenib—thyroid cancer	0.000581	0.0082	CcSEcCtD
Pitavastatin—Abdominal pain—Sorafenib—thyroid cancer	0.000578	0.00816	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—thyroid cancer	0.000566	0.00799	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—thyroid cancer	0.000551	0.00778	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—thyroid cancer	0.00055	0.00776	CcSEcCtD
Pitavastatin—Hypersensitivity—Sorafenib—thyroid cancer	0.000539	0.00761	CcSEcCtD
Pitavastatin—Asthenia—Sorafenib—thyroid cancer	0.000525	0.00741	CcSEcCtD
Pitavastatin—Pruritus—Sorafenib—thyroid cancer	0.000517	0.0073	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—thyroid cancer	0.000509	0.00718	CcSEcCtD
Pitavastatin—Diarrhoea—Sorafenib—thyroid cancer	0.0005	0.00706	CcSEcCtD
Pitavastatin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000492	0.00694	CcSEcCtD
Pitavastatin—Dizziness—Sorafenib—thyroid cancer	0.000483	0.00683	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—thyroid cancer	0.000475	0.00671	CcSEcCtD
Pitavastatin—Rash—Sorafenib—thyroid cancer	0.000461	0.00651	CcSEcCtD
Pitavastatin—Dermatitis—Sorafenib—thyroid cancer	0.000461	0.0065	CcSEcCtD
Pitavastatin—Headache—Sorafenib—thyroid cancer	0.000458	0.00647	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000455	0.00642	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—thyroid cancer	0.00044	0.00621	CcSEcCtD
Pitavastatin—Nausea—Sorafenib—thyroid cancer	0.000434	0.00613	CcSEcCtD
Pitavastatin—Jaundice—Epirubicin—thyroid cancer	0.000413	0.00583	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—thyroid cancer	0.000382	0.0054	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—thyroid cancer	0.00038	0.00537	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000378	0.00534	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—thyroid cancer	0.000352	0.00497	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00035	0.00494	CcSEcCtD
Pitavastatin—Back pain—Epirubicin—thyroid cancer	0.00032	0.00452	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—thyroid cancer	0.000318	0.00449	CcSEcCtD
Pitavastatin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000307	0.00434	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—thyroid cancer	0.000299	0.00422	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—thyroid cancer	0.000296	0.00418	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—thyroid cancer	0.000294	0.00416	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000284	0.00401	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—thyroid cancer	0.000282	0.00398	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—thyroid cancer	0.000282	0.00398	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—thyroid cancer	0.000278	0.00393	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—thyroid cancer	0.000276	0.0039	CcSEcCtD
Pitavastatin—Confusional state—Epirubicin—thyroid cancer	0.000272	0.00385	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—thyroid cancer	0.000261	0.00368	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—thyroid cancer	0.000261	0.00368	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—thyroid cancer	0.000258	0.00364	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—thyroid cancer	0.000252	0.00356	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000246	0.00348	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—thyroid cancer	0.000244	0.00345	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—thyroid cancer	0.000238	0.00336	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—thyroid cancer	0.000233	0.00329	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—thyroid cancer	0.000231	0.00326	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000228	0.00322	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—thyroid cancer	0.000226	0.00319	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—thyroid cancer	0.000223	0.00314	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000221	0.00312	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—thyroid cancer	0.00022	0.00311	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—thyroid cancer	0.000216	0.00304	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—thyroid cancer	0.000215	0.00303	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—thyroid cancer	0.000214	0.00302	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—thyroid cancer	0.000214	0.00302	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000206	0.00291	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000204	0.00289	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—thyroid cancer	0.000199	0.00281	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—thyroid cancer	0.000199	0.0028	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—thyroid cancer	0.000198	0.00279	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—thyroid cancer	0.000194	0.00274	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—thyroid cancer	0.000191	0.0027	CcSEcCtD
Pitavastatin—Diarrhoea—Epirubicin—thyroid cancer	0.000185	0.00261	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000184	0.0026	CcSEcCtD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000182	0.00418	CbGpPWpGaD
Pitavastatin—UGT2B7—Biological oxidations—RXRA—thyroid cancer	0.000182	0.00417	CbGpPWpGaD
Pitavastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000181	0.00415	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—NRG1—thyroid cancer	0.00018	0.00412	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000179	0.00411	CbGpPWpGaD
Pitavastatin—Asthenia—Doxorubicin—thyroid cancer	0.000179	0.00253	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—thyroid cancer	0.000179	0.00252	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—thyroid cancer	0.000177	0.0025	CcSEcCtD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000173	0.00396	CbGpPWpGaD
Pitavastatin—Diarrhoea—Doxorubicin—thyroid cancer	0.000171	0.00242	CcSEcCtD
Pitavastatin—Rash—Epirubicin—thyroid cancer	0.00017	0.00241	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—thyroid cancer	0.00017	0.0024	CcSEcCtD
Pitavastatin—Headache—Epirubicin—thyroid cancer	0.000169	0.00239	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—thyroid cancer	0.000165	0.00233	CcSEcCtD
Pitavastatin—ABCC2—NRF2 pathway—RXRA—thyroid cancer	0.000165	0.00377	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NDUFA13—thyroid cancer	0.000164	0.00376	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—TP53—thyroid cancer	0.000161	0.0037	CbGpPWpGaD
Pitavastatin—Nausea—Epirubicin—thyroid cancer	0.00016	0.00227	CcSEcCtD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.00016	0.00367	CbGpPWpGaD
Pitavastatin—Rash—Doxorubicin—thyroid cancer	0.000158	0.00223	CcSEcCtD
Pitavastatin—UGT1A3—Metabolism—MINPP1—thyroid cancer	0.000157	0.00361	CbGpPWpGaD
Pitavastatin—Dermatitis—Doxorubicin—thyroid cancer	0.000157	0.00222	CcSEcCtD
Pitavastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000157	0.00359	CbGpPWpGaD
Pitavastatin—Headache—Doxorubicin—thyroid cancer	0.000157	0.00221	CcSEcCtD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000155	0.00355	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000155	0.00355	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CHST14—thyroid cancer	0.000154	0.00354	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—HPGD—thyroid cancer	0.000153	0.0035	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—CP—thyroid cancer	0.00015	0.00344	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00015	0.00344	CbGpPWpGaD
Pitavastatin—Nausea—Doxorubicin—thyroid cancer	0.000148	0.0021	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—MINPP1—thyroid cancer	0.000148	0.0034	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000148	0.00338	CbGpPWpGaD
Pitavastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000147	0.00338	CbGpPWpGaD
Pitavastatin—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000147	0.00336	CbGpPWpGaD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000147	0.00336	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000144	0.0033	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—NRG1—thyroid cancer	0.000142	0.00326	CbGpPWpGaD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000139	0.00319	CbGpPWpGaD
Pitavastatin—HMGCR—SREBP signalling—AKT1—thyroid cancer	0.000136	0.00312	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—AKT1—thyroid cancer	0.000136	0.00312	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—MINPP1—thyroid cancer	0.000134	0.00307	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NDUFA13—thyroid cancer	0.000134	0.00307	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000131	0.003	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000126	0.0029	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NDUFA13—thyroid cancer	0.000126	0.00289	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CHST14—thyroid cancer	0.000126	0.00288	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—HPGD—thyroid cancer	0.000124	0.00285	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000124	0.00284	CbGpPWpGaD
Pitavastatin—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000119	0.00274	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CHST14—thyroid cancer	0.000119	0.00272	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000117	0.00269	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000117	0.00269	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000116	0.00266	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000115	0.00264	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NDUFA13—thyroid cancer	0.000114	0.00261	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000114	0.0026	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000112	0.00257	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000109	0.00249	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CHST14—thyroid cancer	0.000107	0.00245	CbGpPWpGaD
Pitavastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000104	0.00238	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—HPGD—thyroid cancer	0.000101	0.00232	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000101	0.00231	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MINPP1—thyroid cancer	9.97e-05	0.00228	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	9.71e-05	0.00222	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—HPGD—thyroid cancer	9.56e-05	0.00219	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.45e-05	0.00216	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MINPP1—thyroid cancer	9.23e-05	0.00211	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	8.86e-05	0.00203	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	8.86e-05	0.00203	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.78e-05	0.00201	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—TPR—thyroid cancer	8.77e-05	0.00201	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PRKAR1A—thyroid cancer	8.63e-05	0.00198	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—HPGD—thyroid cancer	8.63e-05	0.00198	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	8.63e-05	0.00198	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	8.48e-05	0.00194	CbGpPWpGaD
Pitavastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	8.47e-05	0.00194	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	8.39e-05	0.00192	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.39e-05	0.00192	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.29e-05	0.0019	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.25e-05	0.00189	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	8.24e-05	0.00189	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CHST14—thyroid cancer	7.97e-05	0.00183	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	7.88e-05	0.0018	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.88e-05	0.0018	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NDUFA13—thyroid cancer	7.85e-05	0.0018	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.82e-05	0.00179	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—RXRA—thyroid cancer	7.8e-05	0.00179	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.76e-05	0.00178	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.75e-05	0.00178	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CHST14—thyroid cancer	7.38e-05	0.00169	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.38e-05	0.00169	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	7.3e-05	0.00167	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	7.3e-05	0.00167	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	7.29e-05	0.00167	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.18e-05	0.00164	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—TPR—thyroid cancer	7.15e-05	0.00164	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PRKAR1A—thyroid cancer	7.03e-05	0.00161	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.75e-05	0.00155	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	6.75e-05	0.00155	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	6.63e-05	0.00152	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	6.58e-05	0.00151	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—SLC5A5—thyroid cancer	6.57e-05	0.0015	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HPGD—thyroid cancer	6.43e-05	0.00147	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.38e-05	0.00146	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	6.35e-05	0.00145	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.28e-05	0.00144	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	6.25e-05	0.00143	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.15e-05	0.00141	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HPGD—thyroid cancer	5.95e-05	0.00136	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.9e-05	0.00135	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—TPR—thyroid cancer	5.83e-05	0.00133	CbGpPWpGaD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	5.76e-05	0.00132	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PRKAR1A—thyroid cancer	5.73e-05	0.00131	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MINPP1—thyroid cancer	5.73e-05	0.00131	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MINPP1—thyroid cancer	5.7e-05	0.0013	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—RXRA—thyroid cancer	5.52e-05	0.00126	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—TPR—thyroid cancer	5.49e-05	0.00126	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.46e-05	0.00125	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	5.4e-05	0.00124	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.37e-05	0.00123	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—SLC5A5—thyroid cancer	5.35e-05	0.00123	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.28e-05	0.00121	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.21e-05	0.00119	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PRKAR1A—thyroid cancer	5.12e-05	0.00117	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.02e-05	0.00115	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MINPP1—thyroid cancer	4.99e-05	0.00114	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TPR—thyroid cancer	4.96e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.96e-05	0.00114	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—thyroid cancer	4.93e-05	0.00113	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.9e-05	0.00112	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PRKAR1A—thyroid cancer	4.88e-05	0.00112	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.87e-05	0.00112	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NDUFA13—thyroid cancer	4.84e-05	0.00111	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.66e-05	0.00107	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.59e-05	0.00105	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CHST14—thyroid cancer	4.58e-05	0.00105	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CHST14—thyroid cancer	4.55e-05	0.00104	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	4.5e-05	0.00103	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	4.5e-05	0.00103	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—RXRA—thyroid cancer	4.5e-05	0.00103	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.43e-05	0.00101	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.37e-05	0.001	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SLC5A5—thyroid cancer	4.36e-05	0.000999	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.24e-05	0.000972	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	4.11e-05	0.000942	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CHST14—thyroid cancer	3.99e-05	0.000914	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.97e-05	0.000908	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.94e-05	0.000903	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.94e-05	0.000903	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.88e-05	0.000889	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.85e-05	0.000882	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CHST14—thyroid cancer	3.73e-05	0.000854	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SLC5A5—thyroid cancer	3.71e-05	0.00085	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HPGD—thyroid cancer	3.69e-05	0.000846	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TPR—thyroid cancer	3.69e-05	0.000845	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HPGD—thyroid cancer	3.67e-05	0.000841	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—RXRA—thyroid cancer	3.67e-05	0.00084	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.65e-05	0.000836	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	3.63e-05	0.000832	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PPARG—thyroid cancer	3.48e-05	0.000798	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—RXRA—thyroid cancer	3.45e-05	0.000791	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TPR—thyroid cancer	3.42e-05	0.000783	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IFNA2—thyroid cancer	3.39e-05	0.000776	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.37e-05	0.000772	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.36e-05	0.00077	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.36e-05	0.00077	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.29e-05	0.000754	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HPGD—thyroid cancer	3.22e-05	0.000737	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—RXRA—thyroid cancer	3.12e-05	0.000714	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.1e-05	0.000711	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HPGD—thyroid cancer	3.01e-05	0.000688	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.99e-05	0.000686	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.98e-05	0.000682	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.95e-05	0.000676	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PPARG—thyroid cancer	2.84e-05	0.00065	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.83e-05	0.000648	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.8e-05	0.000642	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	2.76e-05	0.000633	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—thyroid cancer	2.74e-05	0.000628	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.71e-05	0.00062	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.59e-05	0.000593	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.56e-05	0.000586	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.48e-05	0.000568	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.44e-05	0.000558	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTEN—thyroid cancer	2.39e-05	0.000547	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.32e-05	0.000532	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPARG—thyroid cancer	2.31e-05	0.00053	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.26e-05	0.000517	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—thyroid cancer	2.23e-05	0.000512	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—thyroid cancer	2.18e-05	0.0005	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RXRA—thyroid cancer	2.15e-05	0.000492	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TPR—thyroid cancer	2.12e-05	0.000486	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TPR—thyroid cancer	2.11e-05	0.000483	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.09e-05	0.000478	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.08e-05	0.000476	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PRKAR1A—thyroid cancer	2.07e-05	0.000475	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—thyroid cancer	1.97e-05	0.000451	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—thyroid cancer	1.95e-05	0.000446	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.89e-05	0.000433	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.88e-05	0.000431	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TPR—thyroid cancer	1.85e-05	0.000423	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.85e-05	0.000423	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—thyroid cancer	1.82e-05	0.000417	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.82e-05	0.000416	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TPR—thyroid cancer	1.73e-05	0.000395	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—thyroid cancer	1.72e-05	0.000393	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.7e-05	0.000389	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—thyroid cancer	1.59e-05	0.000364	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.59e-05	0.000364	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.58e-05	0.000363	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC5A5—thyroid cancer	1.58e-05	0.000362	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.56e-05	0.000357	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—thyroid cancer	1.55e-05	0.000355	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.54e-05	0.000352	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.5e-05	0.000343	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.49e-05	0.000341	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.48e-05	0.000339	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.47e-05	0.000336	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.38e-05	0.000317	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—thyroid cancer	1.38e-05	0.000315	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—thyroid cancer	1.36e-05	0.000311	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—thyroid cancer	1.35e-05	0.000309	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RXRA—thyroid cancer	1.33e-05	0.000305	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RXRA—thyroid cancer	1.33e-05	0.000304	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.3e-05	0.000297	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.000296	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.29e-05	0.000295	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—thyroid cancer	1.26e-05	0.00029	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.21e-05	0.000277	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RXRA—thyroid cancer	1.16e-05	0.000266	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.15e-05	0.000264	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—thyroid cancer	1.12e-05	0.000257	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—thyroid cancer	1.09e-05	0.000249	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RXRA—thyroid cancer	1.09e-05	0.000249	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000244	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.06e-05	0.000242	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.01e-05	0.00023	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—thyroid cancer	9.67e-06	0.000221	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—thyroid cancer	9.31e-06	0.000213	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—thyroid cancer	9.25e-06	0.000212	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—thyroid cancer	9.15e-06	0.00021	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—thyroid cancer	8.62e-06	0.000198	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—thyroid cancer	8.42e-06	0.000193	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—thyroid cancer	8.37e-06	0.000192	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—thyroid cancer	8.17e-06	0.000187	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—thyroid cancer	7.78e-06	0.000178	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—thyroid cancer	7.34e-06	0.000168	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—thyroid cancer	6.85e-06	0.000157	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.62e-06	0.000152	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—thyroid cancer	6.59e-06	0.000151	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—thyroid cancer	5.79e-06	0.000133	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—thyroid cancer	5.78e-06	0.000132	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—thyroid cancer	5.77e-06	0.000132	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—thyroid cancer	5.74e-06	0.000132	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.39e-06	0.000123	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—thyroid cancer	5.37e-06	0.000123	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—thyroid cancer	5.03e-06	0.000115	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—thyroid cancer	4.7e-06	0.000108	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—thyroid cancer	3.33e-06	7.63e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—thyroid cancer	3.31e-06	7.58e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—thyroid cancer	2.9e-06	6.64e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—thyroid cancer	2.71e-06	6.21e-05	CbGpPWpGaD
